Two component ‘bio-ink’ could help advance 3D printing of tissues
Researchers in the UK say they have developed a ‘bio-ink’, which overcomes obstacles holding back the use of 3D printing to make complex tissues.
Researchers in the UK say they have developed a ‘bio-ink’, which overcomes obstacles holding back the use of 3D printing to make complex tissues.
VWR has acquired PAW BioScience Products to expand its single-use portfolio.
Japan's Astellas has agreed to carry out clinical trials of a vaccine for serious diarrhoeal diseases which does not need to be refrigerated or injected and is produced in transgenic rice plants.
UK biopharma company Scancell was forced to halt trials of its flagship cancer immunotherapy SCIB1 because its supplies of the drug no longer meet quality specifications.
Irvine Scientific has launched a medium for neuronal cells for pharmaceutical firms developing regenerative medicines and drugs for central nervous system disorders.